To begin with, AGR2 and ESR1 protein expression has been shown by immunohistochemistry to be positively correlated in both ER+ breast cancer cell lines and ER+ breast tumors [8, 11, 15, 16]. This evidence concerns the gene ESR1 and breast neoplasm.